\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationOnline
ProgrammesThe Commission has announced dedicated Info Days for the EU Missions to inform potential applicants and stakeholders about the new topics (2022 calls) included in the amended EU Missions work programme 2021-2022 under Horizon Europe (published on 10 May 2022).
The Info Days will present a wide range of new topics for all five missions: Cancer, Adaptation to Climate Change, Restore our Ocean and Waters, A Soil Deal for Europe and 100 Climate-Neutral and Smart cities by 2030
For more information and a detailed agenda visit the Commission's event website.
Practical details and information on how to participate will become availabe on this website in advance of the event.
Back-to-back with the Commission Info Days, a Matchmaking Event is organised on 19 May by Bridge2HE, the Network of Horizon Europe National Contact Points.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
